Patent Expiry
XERS: RECORLEV: recorded patent 12377096 expiry
March 2, 2040 · LEVOKETOCONAZOLE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- March 2, 2040
- Company
- Xeris Biopharma Holdings, Inc. (XERS)
- Drug
- LEVOKETOCONAZOLE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
RECORLEV: recorded patent 12377096 expiry
Orange Book application NDA214133, product 001, listed patent 12377096 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- LEVOKETOCONAZOLE